Foster-Cheek Kaye I
Insider CIK 1312622 · ONXX SVP, Global Human Resources · AGIO Director · PRME Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2026-06-18 | 2026-06-23 | 14,950 | — | $0 | 14,950 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2026-06-18 | 2026-06-23 | 2,927 | — | $0 | 2,927 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2026-06-18 | 2026-06-23 | 2,816 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2026-06-18 | 2026-06-23 | 2,816 | — | $0 | 10,284 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2026-06-05 | 2026-06-08 | 75,000 | — | $0 | 75,000 | SEC↗ |
| PRME Prime Medicine, Inc. | D To issuer deriv | 2025-08-01 | 2025-08-05 | 45,000 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2025-08-01 | 2025-08-05 | 39,062 | — | $0 | 39,062 | SEC↗ |
| PRME Prime Medicine, Inc. | D To issuer deriv | 2025-08-01 | 2025-08-05 | 39,062 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2025-08-01 | 2025-08-05 | 9,006 | — | $0 | 9,006 | SEC↗ |
| PRME Prime Medicine, Inc. | D To issuer deriv | 2025-08-01 | 2025-08-05 | 9,006 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2025-08-01 | 2025-08-05 | 13,510 | — | $0 | 13,510 | SEC↗ |
| PRME Prime Medicine, Inc. | D To issuer deriv | 2025-08-01 | 2025-08-05 | 13,510 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2025-08-01 | 2025-08-05 | 45,000 | — | $0 | 45,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2025-06-20 | 2025-06-23 | 2,120 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2025-06-20 | 2025-06-23 | 2,120 | — | $0 | 7,468 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2025-06-18 | 2025-06-23 | 15,768 | — | $0 | 15,768 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2025-06-18 | 2025-06-23 | 2,816 | — | $0 | 2,816 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2025-06-04 | 2025-06-05 | 55,000 | — | $0 | 55,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2024-06-20 | 2024-06-24 | 2,120 | — | $0 | 2,120 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2024-06-20 | 2024-06-24 | 11,774 | — | $0 | 11,774 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2024-06-13 | 2024-06-17 | 3,388 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2024-06-13 | 2024-06-17 | 3,388 | — | $0 | 8,912 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | G Gift | 2024-06-13 | 2024-06-17 | 3,564 | — | $0 | 5,348 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2024-06-12 | 2024-06-14 | 45,000 | — | $0 | 45,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | S Sale | 2024-03-07 | 2024-03-11 | 1,285 | $31.62 | $40.6K | 5,524 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | S Sale | 2024-03-06 | 2024-03-07 | 4,415 | $31.99 | $141.2K | 6,809 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | S Sale | 2024-03-05 | 2024-03-07 | 300 | $32.21 | $9.7K | 11,224 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2023-08-09 | 2023-08-11 | 25,000 | — | $0 | 4,307 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | S Sale | 2023-08-09 | 2023-08-11 | 25,000 | $25.96 | $649.0K | 11,524 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2023-08-09 | 2023-08-11 | 25,000 | $18.09 | $452.3K | 36,524 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2023-06-21 | 2023-06-23 | 4,975 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2023-06-21 | 2023-06-23 | 4,975 | — | $0 | 11,524 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 39,062 | — | $0 | 39,062 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2023-06-13 | 2023-06-15 | 3,388 | — | $0 | 3,388 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2023-06-13 | 2023-06-15 | 18,958 | — | $0 | 18,958 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | G Gift | 2023-01-13 | 2023-01-18 | 2,200 | — | $0 | 6,549 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2022-10-19 | 2022-10-21 | 9,006 | — | $0 | 9,006 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2022-06-21 | 2022-06-23 | 29,307 | — | $0 | 29,307 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2022-06-21 | 2022-06-23 | 4,975 | — | $0 | 4,975 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2022-05-20 | 2022-05-24 | 1,585 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2022-05-20 | 2022-05-24 | 1,585 | — | $0 | 8,749 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2021-05-28 | 2021-06-02 | 1,686 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2021-05-28 | 2021-06-02 | 1,686 | — | $0 | 7,164 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2021-05-20 | 2021-05-24 | 8,888 | — | $0 | 8,888 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2021-05-20 | 2021-05-24 | 1,585 | — | $0 | 1,585 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2020-05-29 | 2020-06-01 | 1,878 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2020-05-29 | 2020-06-01 | 1,878 | — | $0 | 5,478 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2020-05-28 | 2020-06-01 | 1,686 | — | $0 | 1,686 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2020-05-28 | 2020-06-01 | 8,096 | — | $0 | 8,096 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise deriv | 2019-05-31 | 2019-05-31 | 1,400 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise | 2019-05-31 | 2019-05-31 | 1,400 | — | $0 | 3,600 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2019-05-29 | 2019-05-31 | 8,919 | — | $0 | 8,919 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2019-05-29 | 2019-05-31 | 1,878 | — | $0 | 1,878 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise deriv | 2018-06-14 | 2018-06-18 | 9,000 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | S Sale | 2018-06-14 | 2018-06-18 | 839 | $94.30 | $79.1K | 2,200 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | S Sale | 2018-06-14 | 2018-06-18 | 5,980 | $93.78 | $560.8K | 3,039 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | S Sale | 2018-06-14 | 2018-06-18 | 2,181 | $92.62 | $202.0K | 9,019 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise | 2018-06-14 | 2018-06-18 | 9,000 | $50.73 | $456.6K | 11,200 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2018-05-31 | 2018-06-04 | 1,400 | — | $0 | 1,400 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2018-05-31 | 2018-06-04 | 5,700 | — | $0 | 5,700 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise deriv | 2018-03-19 | 2018-03-21 | 6,800 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise | 2018-03-19 | 2018-03-21 | 6,800 | $47.33 | $321.8K | 9,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | S Sale | 2018-03-19 | 2018-03-21 | 6,800 | $81.97 | $557.4K | 2,200 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise deriv | 2018-02-26 | 2018-02-28 | 2,200 | — | $0 | 6,800 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise | 2018-02-26 | 2018-02-28 | 2,200 | $47.33 | $104.1K | 2,200 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2017-06-13 | 2017-06-15 | 9,000 | — | $0 | 9,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2016-06-21 | 2016-06-23 | 9,000 | — | $0 | 45,899 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2015-06-23 | 2015-06-25 | 11,899 | — | $0 | 36,899 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2014-12-09 | 2014-12-10 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 21,172 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 9,917 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 1,750 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 3,407 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 11,660 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 15,100 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 22,059 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer | 2013-10-01 | 2013-10-03 | 21,400 | $125.00 | $2.67M | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | U Tender | 2013-10-01 | 2013-10-03 | 5,666 | $125.00 | $708.3K | 21,400 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2013-08-06 | 2013-08-08 | 1,750 | — | $0 | 11,667 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2013-08-06 | 2013-08-08 | 4,740 | — | $0 | 32,832 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2013-08-06 | 2013-08-08 | 2,388 | — | $0 | 25,466 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2013-08-06 | 2013-08-08 | 8,378 | $132.76 | $1.11M | 27,566 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2013-08-06 | 2013-08-08 | 500 | $133.68 | $66.8K | 27,066 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2013-08-06 | 2013-08-08 | 2,388 | $37.68 | $90.0K | 35,944 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2013-08-06 | 2013-08-08 | 4,740 | $26.38 | $125.0K | 31,806 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2013-08-06 | 2013-08-08 | 1,750 | $35.18 | $61.6K | 33,556 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2013-05-07 | 2013-05-08 | 1,750 | — | $0 | 13,417 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2013-05-07 | 2013-05-08 | 4,740 | — | $0 | 37,572 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2013-05-07 | 2013-05-08 | 2,387 | — | $0 | 27,854 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2013-05-07 | 2013-05-08 | 500 | $90.65 | $45.3K | 27,066 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2013-05-07 | 2013-05-08 | 2,387 | $37.68 | $89.9K | 34,193 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2013-05-07 | 2013-05-08 | 1,750 | $35.18 | $61.6K | 35,943 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2013-05-07 | 2013-05-08 | 4,740 | $26.38 | $125.0K | 31,806 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2013-05-07 | 2013-05-08 | 8,377 | $89.79 | $752.2K | 27,566 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2013-04-02 | 2013-04-03 | 1,767 | $89.62 | $158.4K | 27,066 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2013-04-01 | 2013-04-03 | 2,066 | $86.15 | $178.0K | 28,833 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award deriv | 2013-03-28 | 2013-04-01 | 15,100 | — | $0 | 15,100 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award | 2013-03-28 | 2013-04-01 | 5,400 | — | $0 | 30,899 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2013-02-15 | 2013-02-20 | 3,500 | — | $0 | 15,167 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2013-02-15 | 2013-02-20 | 9,480 | — | $0 | 42,312 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2013-02-15 | 2013-02-20 | 3,184 | — | $0 | 30,241 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2013-02-15 | 2013-02-20 | 16,164 | $74.96 | $1.21M | 25,499 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2013-02-15 | 2013-02-20 | 3,500 | $35.18 | $123.1K | 41,663 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2013-02-15 | 2013-02-20 | 9,480 | $26.38 | $250.1K | 38,163 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2013-02-15 | 2013-02-20 | 3,184 | $37.68 | $120.0K | 28,683 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2012-11-06 | 2012-11-08 | 4,775 | — | $0 | 33,425 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2012-11-06 | 2012-11-08 | 4,775 | $37.68 | $179.9K | 32,611 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2012-11-06 | 2012-11-08 | 7,112 | $75.90 | $539.8K | 25,499 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2012-10-02 | 2012-10-04 | 2,015 | $85.08 | $171.4K | 27,836 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2012-08-06 | 2012-08-08 | 9,333 | — | $0 | 18,667 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2012-08-06 | 2012-08-08 | 12,708 | — | $0 | 51,792 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2012-08-06 | 2012-08-08 | 22,041 | $70.44 | $1.55M | 43,574 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2012-08-06 | 2012-08-08 | 6,644 | $70.48 | $468.3K | 36,930 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2012-08-06 | 2012-08-08 | 9,333 | $35.18 | $328.3K | 52,907 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2012-08-06 | 2012-08-08 | 829 | $71.87 | $59.6K | 36,101 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2012-08-06 | 2012-08-08 | 12,708 | $26.38 | $335.2K | 65,615 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2012-07-25 | 2012-07-27 | 2,335 | $73.97 | $172.7K | 43,574 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer | 2012-04-02 | 2012-04-03 | 505 | $36.58 | $18.5K | 45,909 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award deriv | 2012-03-30 | 2012-04-03 | 38,200 | — | $0 | 38,200 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award | 2012-03-30 | 2012-04-03 | 7,500 | — | $0 | 35,414 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award | 2012-03-30 | 2012-04-03 | 11,000 | — | $0 | 46,414 | SEC↗ |